Royalty Pharma plc Stock Repurchased During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Royalty Pharma plc stock repurchased during period, shares for the quarter ending 2023-09-30 was 4.86M shares.
- Royalty Pharma plc stock repurchased during period, shares for the quarter ending 2023-06-30 was 4.03M shares.
- Royalty Pharma plc stock repurchased during period, shares for fiscal 2024 was 8.40M shares, a 14.66% decline from fiscal 2023.
- Royalty Pharma plc stock repurchased during period, shares for fiscal 2023 was 9.85M shares.
| Period end | Stock Repurchased During Period, Shares 3 month | Stock Repurchased During Period, Shares 12 month |
|---|---|---|
| 2024-12-31 | 8.40M shares 10-K · filed 2025-02-12 | |
| 2023-12-31 | 9.85M shares 10-K · filed 2025-02-12 | |
| 2023-09-30 | 4.86M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 4.03M shares 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |